Gaddam S, Singh M, Balasubramanian G, Gupta N, Wani S, Higbee AD, et al. Persistence of Non-Dysplastic Barrett's Esophagus Identifies Patients at Lower Risk for Esophageal Adenocarcinoma-Results from a Large Multicenter Cohort. Gastroenterology 2013 May 25 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/23714382.
Compare quality appraisals for each clinical question
- What is the incidence of neoplasia in patients with BO?
- What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?
- Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
- Are there groups of patients with BO that can be discharged from surveillance?